Regulation of human eosinophil serine protease 1-like enzyme
US7060810B2 · kind B2 · utility
2Cited by
1References
17Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 29, 2003 |
| Grant date | Jun 13, 2006 |
| Priority date | — |
| Expiry date | Jan 2, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A human eosinophil serine protease 1-like enzyme, cDNA, and reagents that regulate the enzyme can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, asthma, COPD, airway allergy, and osteoporosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.